AstraZeneca PLC (AZN.L) Price/Sales Ratio

Price: $11316
Market Cap: $175.47B
Avg Volume: 2.74M
Country: GB
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.157
52W Range: $9670-13388
Website: AstraZeneca PLC

What is AstraZeneca PLC's Price/Sales Ratio?

  • AstraZeneca PLC's trailing twelve month (TTM) Price/Sales ratio is 4.20.
  • AstraZeneca PLC's annual Price/Sales ratio as of today is 3.76.
  • AstraZeneca PLC's quarterly Price/Sales ratio is 13.67.

What is the Price/Sales Ratio?

The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.

How is the Price/Sales Ratio calculated?

The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:

P/S Ratio = Market Capitalization / Total Sales (Revenue)

Related Metrics

Other important metrics to assess AstraZeneca PLC's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: 28.93
    • Quarterly: 33.92
    • TTM: 32.33
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 4.99
    • Quarterly: 4.99
    • TTM: 5.58
  • P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: 17.16
    • Quarterly: 70.01
    • TTM: 19.17
  • PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
    • Annual: 1.53
    • Quarterly: 6.24
    • TTM: 3.75

These metrics provide insights into AstraZeneca PLC's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Price/Sales Ratio

3.76

Quarterly Price/Sales Ratio

13.67

TTM Price/Sales Ratio

4.20

AstraZeneca PLC Historical Price/Sales Ratio
6.006.005.005.004.004.003.003.002.002.001.001.000.000.00Price/Sales Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical P/E Ratio
1600.001600.001200.001200.00800.00800.00400.00400.000.000.00P/E Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical P/B Ratio
10.0010.008.008.006.006.004.004.002.002.000.000.00P/B Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical P/C Ratio
50.0050.0040.0040.0030.0030.0020.0020.0010.0010.000.000.00P/C Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical PEG Ratio
4.004.000.000.00-4.00-4.00-8.00-8.00-12.00-12.00-16.00-16.00PEG Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025

AstraZeneca PLC Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Price/Sales Ratio P/E Ratio P/B Ratio P/C Ratio PEG Ratio
2024 3.76 28.93 4.99 17.16 1.53
2023 4.60 35.42 5.39 20.39 0.44
2022 4.73 63.83 5.67 21.40 0.03
2021 4.45 1486.79 4.24 27.93 -15.37
2020 4.93 41.06 8.40 27.34 0.30
2019 5.38 98.23 9.99 44.17 -2.49
2018 4.29 43.99 7.60 36.21 -1.56
2017 3.90 29.18 5.85 24.48 -2.02
2016 3.01 19.78 4.66 16.70 0.82
2015 3.48 30.43 4.65 25.86 0.24

Related Metrics

Explore detailed financial metrics and analysis for AZN.L.